Steris (STE) Issues FY 2019 Earnings Guidance

Share on StockTwits

Steris (NYSE:STE) updated its FY 2019 earnings guidance on Monday. The company provided EPS guidance of $4.74-4.84 for the period, compared to the Thomson Reuters consensus EPS estimate of $4.76. The company issued revenue guidance of $2.751-2.751 billion, compared to the consensus revenue estimate of $2.75 billion.

A number of research firms have issued reports on STE. KeyCorp raised their target price on Steris from $120.00 to $132.00 and gave the stock an overweight rating in a research report on Tuesday, November 13th. Zacks Investment Research reissued a buy rating and issued a $132.00 target price on shares of Steris in a research report on Friday, November 16th. Finally, Sidoti raised their target price on Steris from $155.00 to $157.00 and gave the stock a buy rating in a research report on Thursday, December 6th. Five research analysts have rated the stock with a buy rating, The stock currently has an average rating of Buy and a consensus price target of $134.20.

Shares of NYSE STE traded up $1.27 during mid-day trading on Monday, hitting $119.86. The company had a trading volume of 772,423 shares, compared to its average volume of 413,651. The stock has a market cap of $10.03 billion, a PE ratio of 28.88 and a beta of 1.04. Steris has a 1 year low of $83.44 and a 1 year high of $121.67. The company has a debt-to-equity ratio of 0.41, a quick ratio of 2.01 and a current ratio of 2.63.

In other news, VP John Adam Zangerle sold 1,750 shares of Steris stock in a transaction on Friday, January 11th. The stock was sold at an average price of $110.00, for a total value of $192,500.00. Following the completion of the transaction, the vice president now directly owns 32,546 shares in the company, valued at $3,580,060. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. 2.38% of the stock is currently owned by insiders.

ILLEGAL ACTIVITY NOTICE: This story was originally published by Highlight Press and is the sole property of of Highlight Press. If you are viewing this story on another website, it was copied illegally and reposted in violation of United States & international trademark and copyright legislation. The original version of this story can be accessed at https://highlightpress.com/2019/02/11/steris-ste-issues-fy-2019-earnings-guidance.html.

Steris Company Profile

STERIS plc provides infection prevention and other procedural products and services worldwide. The company operates in four segments: Healthcare Products, Healthcare Specialty Services, Life Sciences, and Applied Sterilization Technologies. The Healthcare Products segment offers cleaning chemistries and sterility assurance products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operations of a sterile processing department; and equipment used in the operating room, including surgical tables, lights, equipment management services, and connectivity solutions.

Featured Story: Cost of Capital Explained

Earnings History and Estimates for Steris (NYSE:STE)

Receive News & Ratings for Steris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Steris and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply